Journal of Alzheimer s Disease · 2019 · 16 citations · 28 references
MedicineGeriatric MedicinePharmacotherapyDementiaGeriatric PharmacotherapyGeriatricsAlzheimer DiseaseDementia EpidemiologyDementia PreventionDementia PrognosisDementia Risk FactorsDementia TreatmentAge-specific Dementia RatesAlzheimer Disease ProgressionAlzheimer Disease RiskComorbidity Effects On PrognosisDementia MortalityDementia Survival AnalysisGeriatric Medication Risk StratificationSex Differences In Dementia
BACKGROUND: Recent evidence indicates an important role for neuroinflammation in the pathological cascade of Alzheimer's disease (AD), and neuroinflammation is increasingly being recognized as a potential therapeutic target. OBJECTIVE: To assess the impact of glucocorticoids on the risk of developing dementia. METHODS: We used health insurance data of the largest German health insurer from 2004-2013 with a baseline sample of 176,485 persons aged 50 years and older to study the association of glucocorticoid treatment and incidence of dementia. Cox proportional-hazard models were calculated adjusting for sex, age, and comorbidities known to be major risk factors for dementia and were given as hazard ratios (HR) with 95% confidence intervals (CI). We further stratified glucocorticoid treatment by route of application and treatment duration. RESULTS: Of the 176,485 dementia-free persons, 19,938 were diagnosed with dementia by the end of 2013. The risk of suffering from dementia was significantly lower for glucocorticoid users compared to non-users (HR = 0.81, CI = 0.78-0.84). The lowest risk was found among users of inhaled glucocorticoid (HR = 0.65, CI = 0.57-0.75), followed by nasal (HR = 0.76, CI = 0.66-0.87), other (HR = 0.84, CI = 0.80-0.88), and oral users (HR = 0.83, CI = 0.78-0.88). We found no difference in risk reduction between long- and short-term-users. CONCLUSION: Longitudinal German health insurance data indicate that the use of glucocorticoids is associated with a lower risk of dementia. Prospective clinical trials will be necessary to determine whether glucocorticoids can have a positive impact on neuroinflammation and thus protect persons against dementia.
28
Cortisol levels during human aging predict hippocampal atrophy and memory deficits
Sonia Lupien, Mony J. de Leon, Susan De Santi et al. · Nature Neuroscience · 1998 · 1.6K citations
Steroid hormone receptor expression and function in microglia
Amanda Sierra, Andres Gottfried‐Blackmore, Teresa A. Milner et al. · Glia · 2008 · 398 citations · Full text
Francisco Ros‐Bernal, Stéphane Hunot, María Trinidad Herrero et al. · Proceedings of the National Academy of Sciences · 2011 · 238 citations